Our focus is patients, 
Our passion is innovation®

MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.


Advanced Science 
Practical Design

We specialize in innovative technologies with proven ease-of-use and patient acceptance.


Inhalation Treatments

Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.


In Partnership
Your Drug, Our Delivery.

Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.


About Us

MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes.  More





facebook-c_130x50      twitter_130x50


MannKind CEO, Michael Castagna, was recently interviewed on SiriusXM Business Radio Powered by The Wharton School. The show has shared the audio file of the 25-minute interview about Afrezza. Find it here



FDA Approved

For information about AFREZZA®,
please visit www.AFREZZA.com.


If you are reporting an Adverse Event and/or device complaint, please contact MannKind Medical Information at 1-877-323-8505 or MannKind@druginfo.com. Do not use this form for adverse events and/or device complaints.